ART with long-term effects without immunosuppression

Published Date: 02 Mar 2023

The latest studies of long-acting ART show benefits even in people who are not immune. Meanwhile, early proof-of-concept results for twice-yearly injection are encouraging.

Read Full News

Latest News

Kennedy Allies Petition to Broaden US Vaccine Injury List

An anti-vaccine group aligned with U.S. Health Secretary Robert F. Kennedy Jr. is petitioning him to vastly broaden a federal list to include more than 300 injuries it says...

Kids Confirmed as Top Transmitters of RSV

New modeling data support targeted prevention efforts.

Kent Meningitis Outbreak Triggers Surge in UK Vaccine Demand, Policy Debate

Young people in southeast England and beyond are lining up for the meningitis B vaccine after an outbreak killed two people, sparking supply warnings from pharmacies and...

Parasitic Worms Provide Insights on RSV Prevention

Researchers identify metabolite alternatives to helminth-influenced protection.

Viral Coinfection May Predict Bacteremic Pneumonia

Patients with respiratory viral co-infection may have an increased risk of developing bacteremic Staphylococcus aureus pneumonia and 30-day mortality compared with those without viral co-infection.

UK Says Vaccine Protects Against Strain in Deadly Meningitis Outbreak

Britain's health authorities said on Friday that early laboratory analysis had shown the vaccine being ⁠offered to students should protect against the strain of meningitis...

Todays Updates

Can MRI Curb Chemo Overtreatment in Breast Cancer?

MRI offers the possibility of personalized neoadjuvant chemotherapy for patients with HER2-positive breast cancer, but it may not be ready for prime time.

Subcutaneous Toripalimab Matches IV Formulation in NSCLC

Patients with non-squamous non-small cell cancer may achieve similar outcomes with a subcutaneous formulation of the immunotherapy toripalimab as with IV administration.

New Gene Therapy Nears EU Nod for Bladder Cancer

Conditional approval of intravesical gene therapy was supported by clinical evidence showing a 53.4% complete response rate in patients with treatment-resistant non-muscle-invasive bladder cancer.

CAR T-Cell Therapy Shows Promise in Mantle Cell Lymphoma

A phase 2 study evaluates the safety and efficacy of brexucabtagene autoleucel in BTKi-naïve patients with relapsed/refractory mantle cell lymphoma.

Todays Updates

Can MRI Curb Chemo Overtreatment in Breast Cancer?

MRI offers the possibility of personalized neoadjuvant chemotherapy for patients with HER2-positive breast cancer, but it may not be ready for prime time.

Subcutaneous Toripalimab Matches IV Formulation in NSCLC

Patients with non-squamous non-small cell cancer may achieve similar outcomes with a subcutaneous formulation of the immunotherapy toripalimab as with IV administration.

New Gene Therapy Nears EU Nod for Bladder Cancer

Conditional approval of intravesical gene therapy was supported by clinical evidence showing a 53.4% complete response rate in patients with treatment-resistant non-muscle-invasive bladder cancer.

CAR T-Cell Therapy Shows Promise in Mantle Cell Lymphoma

A phase 2 study evaluates the safety and efficacy of brexucabtagene autoleucel in BTKi-naïve patients with relapsed/refractory mantle cell lymphoma.

Latest News

An anti-vaccine group aligned with U.S. Health Secretary Robert F. Kennedy Jr. is petitioning him to vastly broaden a federal list to include more than 300 injuries it says...

New modeling data support targeted prevention efforts.

Young people in southeast England and beyond are lining up for the meningitis B vaccine after an outbreak killed two people, sparking supply warnings from pharmacies and...

Researchers identify metabolite alternatives to helminth-influenced protection.

Patients with respiratory viral co-infection may have an increased risk of developing bacteremic Staphylococcus aureus pneumonia and 30-day mortality compared with those without viral co-infection.

Britain's health authorities said on Friday that early laboratory analysis had shown the vaccine being ⁠offered to students should protect against the strain of meningitis...

News All Time

US Insurers and Hospitals Turn to New AI for Age-old Battle Over Charges Vs Payments

Artificial intelligence is being deployed on both sides of the tug-of-war between U.S. healthcare systems that want to be paid more for medical procedures and insurers who...

Viatris Settles lawsuit Over Use Of Woman's 'immortal' Cells to Power Drug Research

Generic drugmaker Viatris has settled a lawsuit brought by the family of Henrietta Lacks, a Maryland woman whose ⁠tissue samples were used without her permission to develop...

RSV Hospitalization Burden Rises With Age and Comorbidities

Respiratory syncytial virus is associated with a greater burden of hospitalizations in older adults and in those with congestive heart failure or chronic obstructive pulmonary disease.

US Vaccine Advisers Drop Plan to Question MRNA COVID Shots, WaPo Reports

A key U.S. federal vaccine advisory panel has dropped a push against COVID mRNA vaccines, ⁠the Washington Post reported on Wednesday, citing two people familiar with the...

No Link Between HPV Vaccination and Infertility

A Cochrane review of 225 studies covering 132 million vaccinated people found, with high certainty, that HPV vaccination does not cause fertility problems, refuting a common myth.

South Carolina Reports One Additional Measles Case, Total Cases Rise to 991

Measles cases in South Carolina rose to 991 on Friday, state health data ⁠showed, an increase of one case since Tuesday as the nation's largest outbreak in ⁠decades shows...

mRNA RSV Vaccine Safe in Transplant Recipients

mRNA-1345 vaccine is safe and well tolerated and elicits measurable antibody and cellular immune responses in recipients with solid organ transplant.

HIV Hits the Nervous System Early

Cerebrospinal fluid samples show signs of inflammation.

Exercise Training Benefits HIV Patients Below the Surface

Genetic analysis shows signs of cellular repair and slower aging.

Dolutegravir Shows Continued Success in Youth With HIV

Dolutegravir reduces viral load in adolescents and children in low- to middle-income nations.

US CDC Deploys Staff to Curb South Carolina's Measles Outbreak

(Refiles to remove extraneous word years from first paragraph)

After FDA Declined Review, EMA Backs 1st Flu-COVID mRNA Vax

The Moderna vaccine will likely be available in Europe long before the US.

Peak Anti-HBs Level May Predict Protection in HIV Infection

Peak anti-hepatitis B surface antibody levels predicted increased viral protection in HIV, a French study shows.

Doravirine Plus Islatravir Matches Standard HIV Therapy

In patients with HIV‑1 infection and virologic suppression, switching to an investigational regimen of doravirine plus islatravir shows efficacy and safety similar to standard ART regimens.

European Guidance Advances Cardiovascular Risk Assessment

The 2025 update integrates new risk estimation tools and shifts acute coronary syndrome management toward earlier intensive lipid-lowering therapy.

Exclusive-US Postpones Third Consecutive Meeting Of Preventive Health Panel

The March meeting of the U.S. advisory panel that determines what cancer screenings and other preventive health measures insurers must cover has been postponed, according to...

Recommended News For You

Formaldehyde releasers found in common personal care products used especially by Black and Latina women

Patients with head and neck cancer who cannot receive cisplatin now have new hope.

Additional imaging techniques can detect early stage cancers missed by mammograms in women with dense breasts

How artificial intelligence could significantly improve the prognosis for cancer patients.

The Truth About Apple AirPods

In patients with prostate cancer, second-generation antiandrogens may worsen fatigue, falls, and cognitive decline.

Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness

Recommended Articles For You

Transforming Cancer Care: Metrics, Informatics, Equity, and Real-World Evidence 

A New Dawn for Triple-Negative Breast Cancer: Emerging Therapies and the Art of Healing 

A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities 

Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

These Athletes Weren't Doping. Their Genes Made It Look Like They Did.

2.

High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer

3.

New protocols, according to a study, allow many patients to safely return home one day after lung cancer surgery.

4.

Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma

5.

Researchers discover cellular 'doorway' exploited by cancer-causing virus

1.

Toripalimab + Nab-Paclitaxel in PD-L1+ TNBC: Phase 3 TORCHLIGHT Trial Results

2.

Unlocking the Secrets of Leukemic Stem Cells: A Path to Better Blood Cancer Treatments

3.

HSC Failure in Fanconi Anemia: Mechanisms, Models, and Emerging Therapeutic Pathways

4.

What You Need To Know About Secondary Polycythemia: Treatment & Symptoms

5.

Vaso Occlusive Crisis: Understanding the Painful Reality of Sickle Cell Disease

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Efficient Management of First line ALK-rearranged NSCLC - Part II

2.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII

3.

Exploring the Hospitalization Burden in Refractory and Relapsed ALL

4.

Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion

5.

Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot